Skip to content
Search

Latest Stories

Submit Guest Post

Scientists discover link between yoga and reduced cancer relapse risk

Lead researcher Karen Mustian explained that yoga has been shown to help cancer patients with issues such as insomnia

Scientists discover link between yoga and reduced cancer relapse risk

Doctors attending a global cancer conference have suggested that prescribing yoga classes to cancer survivors can reduce the risk of relapse, The Times reported.

Leading scientists have found that advising patients to take it easy can be detrimental.


Trials have shown that engaging in daily 30-minute walks and exercise classes can lead to lower rates of post-cancer problems and a decreased risk of cancer recurrence and death.

One study conducted by a US team revealed that taking two yoga classes a week for a month significantly reduced inflammation in cancer survivors.

Researchers presented these findings at the American Society of Clinical Oncology's annual meeting in Chicago.

The study at the University of Rochester, New York state involved over 500 patients, primarily women who had recovered from breast cancer. They were assigned to either participate in gentle yoga sessions twice a week for four weeks or attend health education sessions.

Blood samples taken before and after the four-week period showed significantly lower levels of inflammation markers in the yoga group compared to the education group.

Lead researcher Karen Mustian explained that yoga has been shown to help cancer patients with issues such as insomnia, and their team aimed to investigate the underlying biology.

Lowering inflammation is crucial as it is associated with cancer progression, long-term side effects, and other problems.

Mustian emphasised the importance of yoga, stating that it significantly reduces inflammation more than educational or peer-support classes.

The yoga sessions used in the study were gentle Hatha and restorative yoga, with poses modified for patients who had trouble standing.

The researchers plan to follow up with the participants to determine if lowering inflammation translates into improved survival rates.

Mustian noted a shift in the attitude towards exercise for cancer patients, as 80% of the oncologists in a conference poll recommended exercise.

Another study presented at the conference by the same team revealed that prescribing yoga to cancer patients over 60 years old can alleviate fatigue and improve their quality of life.

Dr Melissa Hudson, an expert in cancer survival, emphasised that in the past, patients were advised to rest and take it easy. However, recent "outstanding evidence" supports the benefits of physical activity, prompting oncologists to encourage patients to be as active as they can tolerate based on their symptoms.

Additionally, a separate study conducted by Brazilian researchers found that physically active cancer patients at the time of diagnosis were significantly less likely to die within six months.

The lead researcher, Dr Jurema Telles de Oliveira Lima, suggested that even three weeks of rehabilitation could change a patient's risk level.

Inflammation, which is part of the body's response to infection or injury, can have both physical and mental health implications. It has been linked to various health problems, including arthritis, cancer, cardiovascular disease, and type 2 diabetes.

In cancer, higher levels of inflammation are associated with higher relapse rates.

The study on yoga lowering inflammation markers in the blood is significant as it demonstrates that just eight sessions of gentle yoga over a month can significantly reduce inflammation.

Previous research had shown the benefits of yoga after cancer treatment, but this study compared yoga with a social element to confirm the specific benefits of yoga.

Other studies have also highlighted the importance of weight management, exercise, alcohol in moderation, a healthy diet, and sleep in keeping inflammation in check.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weight loss pill

Foundayo is the latest GLP-1 treatment to receive UK approval in tablet form

Representational image: iStock

UK becomes first European nation to approve new weight-loss pill, but NHS access is still pending

  • The UK is the first European country to approve Eli Lilly’s Foundayo pill.
  • The tablet is taken once a day without food or water restrictions.
  • NHS availability will depend on a separate NICE assessment.

The UK has become the first European nation to approve a new daily weight-loss pill, giving patients another option beyond the injectable treatments that have dominated the GLP-1 market.

The Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly’s orforglipron, sold under the brand name Foundayo, on August 10 for weight management and to improve blood sugar control in adults with type 2 diabetes.

Keep ReadingShow less